303 related articles for article (PubMed ID: 22003003)
1. Personalized vascular medicine: individualizing drug therapy.
Degoma EM; Rivera G; Lilly SM; Usman MH; Mohler ER
Vasc Med; 2011 Oct; 16(5):391-404. PubMed ID: 22003003
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.
Vanichakarn P; Hwa J; Stitham J
Curr Mol Med; 2014; 14(7):849-79. PubMed ID: 25109793
[TBL] [Abstract][Full Text] [Related]
3. The next 10 years in personalized medicine in cardiology.
Tantry US; Gurbel PA
Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):933-5. PubMed ID: 23984921
[No Abstract] [Full Text] [Related]
4. Novel treatments for cardiovascular disease prevention.
Huffman MD; Bhatnagar D
Cardiovasc Ther; 2012 Oct; 30(5):257-63. PubMed ID: 21884014
[TBL] [Abstract][Full Text] [Related]
5. The Role of Pharmacogenetics in Antithrombotic Therapy Management: New Achievements and Barriers Yet to Overcome.
Conti V; Corbi G; Manzo V; Sellitto C; Iannello F; Esposito S; De Bellis E; Iannaccone T; Filippelli A
Curr Med Chem; 2021; 28(32):6675-6703. PubMed ID: 33390104
[TBL] [Abstract][Full Text] [Related]
6. Personalized medicine and antiplatelet therapy: ready for prime time?
Verstuyft C; Simon T; Kim RB
Eur Heart J; 2009 Aug; 30(16):1943-63. PubMed ID: 19638479
[No Abstract] [Full Text] [Related]
7. The pharmacogenetics of antiplatelet agents: towards personalized therapy?
Ahmad T; Voora D; Becker RC
Nat Rev Cardiol; 2011 Aug; 8(10):560-71. PubMed ID: 21826075
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive medical management of peripheral arterial disease.
Gandhi S; Weinberg I; Margey R; Jaff MR
Prog Cardiovasc Dis; 2011; 54(1):2-13. PubMed ID: 21722781
[TBL] [Abstract][Full Text] [Related]
9. Medical and lifestyle management of peripheral arterial disease.
Parvar SL; Fitridge R; Dawson J; Nicholls SJ
J Vasc Surg; 2018 Nov; 68(5):1595-1606. PubMed ID: 30360849
[TBL] [Abstract][Full Text] [Related]
10. Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis.
Ma TT; Wong ICK; Man KKC; Chen Y; Crake T; Ozkor MA; Ding LQ; Wang ZX; Zhang L; Wei L
PLoS One; 2019; 14(1):e0210988. PubMed ID: 30657781
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for peripheral artery disease.
Duprez DA
Expert Opin Pharmacother; 2007 Jul; 8(10):1465-77. PubMed ID: 17661729
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs.
Stitham J; Vanichakarn P; Ying L; Hwa J
Curr Mol Med; 2014; 14(7):909-31. PubMed ID: 25109796
[TBL] [Abstract][Full Text] [Related]
13. [Primary nutritional and drug prevention of atherosclerosis].
Monnier L; Avignon A; Colette C; Piperno M
Rev Med Interne; 1999 Aug; 20 Suppl 3():360s-370s. PubMed ID: 10480187
[TBL] [Abstract][Full Text] [Related]
14. Underutilisation of cardiovascular medications among at-risk individuals.
Lewis SJ; Robinson JG; Fox KM; Grandy S;
Int J Clin Pract; 2010 Apr; 64(5):604-10. PubMed ID: 19909379
[TBL] [Abstract][Full Text] [Related]
15. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
Pulley JM; Denny JC; Peterson JF; Bernard GR; Vnencak-Jones CL; Ramirez AH; Delaney JT; Bowton E; Brothers K; Johnson K; Crawford DC; Schildcrout J; Masys DR; Dilks HH; Wilke RA; Clayton EW; Shultz E; Laposata M; McPherson J; Jirjis JN; Roden DM
Clin Pharmacol Ther; 2012 Jul; 92(1):87-95. PubMed ID: 22588608
[TBL] [Abstract][Full Text] [Related]
16. [Secondary prevention of cardiovascular and cerebrovascular complications after ischemic stroke].
Ostroumova OD; Bondarets OV
Kardiologiia; 2014; 54(5):80-7. PubMed ID: 25177893
[TBL] [Abstract][Full Text] [Related]
17. [Risk factor control and treatment of atherothrombosis. Spain REACH Registry].
Suárez C; Cairols M; Castillo J; Esmatjes E; Sala J; Llobet X; Palma JC;
Med Clin (Barc); 2007 Oct; 129(12):446-50. PubMed ID: 17953908
[TBL] [Abstract][Full Text] [Related]
18. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Vandvik PO; Lincoff AM; Gore JM; Gutterman DD; Sonnenberg FA; Alonso-Coello P; Akl EA; Lansberg MG; Guyatt GH; Spencer FA
Chest; 2012 Feb; 141(2 Suppl):e637S-e668S. PubMed ID: 22315274
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
20. The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts.
Moon JY; Franchi F; Rollini F; Angiolillo DJ
Expert Rev Hematol; 2018 Jan; 11(1):5-12. PubMed ID: 29091481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
